D.R. Horton

DHI's lowered FY2025 guidance has played out as discussed in our last article, attributed to the impacted consumer demand and uncertain macroeconomic headwinds. With borrowing costs still elevated, it goes without saying that the homebuilding sector is likely to remain impacted in the intermediate term, DHI included. Even so, it is undeniable that DHI is cheap compared to our fair value estimates, with the recent meltdown already triggering rich double digit upside potential.» Mehr auf seekingalpha.com

Despite weak housing numbers and downward revisions in revenue and home closings in the short-term, D.R. Horton's long-term prospects remain good. DHI's capital allocation strategy includes significant share repurchases and dividends, indicating a commitment to returning value to shareholders. Gross margins were better than expected, while management is focused on balancing growth with consistent cash flows and returns to shareholders.» Mehr auf seekingalpha.com

I track 50 high-quality dividend growth stocks to identify opportune investments, updating valuation ratings daily to focus on attractive opportunities. Despite a market sell-off, my investable universe outperformed SPY and SCHD year-to-date, with a loss of -1.83% compared to -5.49% and -4.64%. This month, 17 stocks had valuation rating changes; 10 were upgrades, including Jack Henry & Associates, West Pharma, and EOG Resources, all with strong expected returns.» Mehr auf seekingalpha.com